Previous Page  11 / 14 Next Page
Information
Show Menu
Previous Page 11 / 14 Next Page
Page Background

Tissue Science 2019

June 17-18, 2019

London, UK

Advances in Tissue

Engineering and

Biomaterials Science

13

th

Edition of International Conference on

Journal of Biomedical Sciences

ISSN: 2254-609X

Page 39

J Biomedical Sci 2019, Volume 08

LTP modified vascular graft materials for endothelial cells

growth

Komal Vig

1

Kendra Swain

1

, Takura Mlambo

1

, Paul Baker

2

, Bernabe Tucker

2

,

Vinoy Thomas

2

and

Yogesh Vohra

2

1

Alabama State University,USA

2

University of Alabama at Birmingham, USA

C

ardiovascular disease (CVD) is the no. 1 killer in the

world, and is responsible for >17.3 million deaths

every year1. Bypass surgery, using the autologous vein

has been one of the most effective treatments for CVD.

However, more recently vascular grafts have shown great

potential in bypass surgery. Vascular grafts currently

employ a number of scaffold materials such as Dacron

and ePTFE and treatments that mimic the native vessel

wall2-3. These however, does not work well for small

diameter grafts (<6 mm) due to intimal hyperplasia

and thrombosis. In our study we plan to improve the

endothelialization of intimal surface of graft bymodifying

with low temperature plasma (LTP) to increase the cell

attachment/viability and proliferation. The scaffolds were

treated with LTP using Harris Plasma Cleaner system

with air as the feed gas for 30 sec at 45W (HI setting).

X ray photoelectron spectroscopic analyses and contact

angle wettability studies confirmed the introduction of

oxygenated functionalities on the surface and enhanced

hydrophilicity due to the improvement in oxygen content

~1 in the graft surface from LTP air plasma. Scaffolds

were also modified with fibronectin and collagen by

dipping method. Endothelial cell studies by microscopic

and metabolic assays indicated that cell viability

increased in LTP treated scaffolds especially when

treated with protein. Scaffolds treated with fibronectin

or collagen had cells viable for a week compared to

untreated samples. MTT results validated the improved

number of metabolically active viable cells. Work is under

progress to improve cell viability on these scaffolds.

komalvig@alasu.edu